Skip to main content

Health Services Research for Opioid Use Disorders

  1. Dispensations of opioid analgesics to patients on opioid agonist therapy (OAT) may increase the risk of overdoses. The current study’s objectives are to investigate the dispensation rates and mean daily doses ...

    Authors: Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Kjell Arne Johansson and Lars Thore Fadnes
    Citation: BMC Health Services Research 2020 20:668
  2. Substantial improvements have been observed in coverage and access to maternal health services in Ethiopia. However, the quality of care has been lagging behind. Therefore, this study aimed to assess the level...

    Authors: Kiros Fenta Ajemu and Alem Desta
    Citation: BMC Health Services Research 2020 20:547
  3. Opioid overdoses are at an epidemic in the United States causing the deaths of thousands each year. Project DAWN (Deaths Avoided with Naloxone) is an opioid overdose education and naloxone distribution program...

    Authors: Joan Papp, Mayur Vallabhaneni, Ariel Morales and Jon W. Schrock
    Citation: BMC Health Services Research 2019 19:957
  4. Addiction health service researchers have focused efforts on opioid use disorder (OUD) and strategies to address the emerging public health threats associated with the epidemics of opioid use and opioid overdo...

    Authors: Kim A. Hoffman, Javier Ponce Terashima and Dennis McCarty
    Citation: BMC Health Services Research 2019 19:884
  5. The CTN-0067 CHOICES trial tests implementation of extended-release naltrexone (XR-NTX) versus treatment-as-usual (TAU) for opioid use disorders (OUD) in HIV clinics to improve HIV viral suppression. The study...

    Authors: Kim A. Hoffman, Robin Baker, Lynn E. Kunkel, Elizabeth Needham Waddell, Paula J. Lum, Dennis McCarty and P. Todd Korthuis
    Citation: BMC Health Services Research 2019 19:862
  6. In order to address the opioid crisis in North America, many regions have adopted preventative strategies, such as prescription drug monitoring programs (PDMPs). PDMPs aim to increase patient safety by certify...

    Authors: Emily Rhodes, Maria Wilson, Alysia Robinson, Jill A. Hayden and Mark Asbridge
    Citation: BMC Health Services Research 2019 19:784
  7. Although opioid agonist therapy is effective in treating opioid use disorders (OUD), retention in opioid agonist therapy is suboptimal, in part, due to quality of care issues. Therefore, we sought to describe ...

    Authors: Laura Beamish, Zach Sagorin, Cole Stanley, Krista English, Rana Garelnabi, Danielle Cousineau, Rolando Barrios and Jan Klimas
    Citation: BMC Health Services Research 2019 19:663
  8. As the effect of opioid maintenance treatment (OMT) on overdose mortality varies both between and within countries, treatment programs need to be evaluated in different treatment settings and over time within ...

    Authors: Anne Bukten, Marianne Riksheim Stavseth and Thomas Clasuen
    Citation: BMC Health Services Research 2019 19:553
  9. Contingency management (CM) is one of the only behavioral interventions shown to be effective for the treatment of opioid use disorders when delivered alone and in combination with pharmacotherapy. Despite ext...

    Authors: Sara J. Becker, Kelli Scott, Cara M. Murphy, Melissa Pielech, Samantha A. Moul, Kimberly R. Yap and Bryan R. Garner
    Citation: BMC Health Services Research 2019 19:466
  10. Mortality rates and causes of death among individuals in opioid agonist treatment (OAT) vary according to several factors such as geographical region, age, gender, subpopulations, drug culture and OAT status. ...

    Authors: Anne Berit Bech, Thomas Clausen, Helge Waal, JÅ«ratÄ— Å altytÄ— Benth and Ivar Skeie
    Citation: BMC Health Services Research 2019 19:440
  11. Given its role in treating musculoskeletal conditions, rehabilitation medicine may be an important factor in decreasing the use of opioids among injured workers. The primary objective was to determine if incre...

    Authors: Alyson K. Kwok, Nathan N. O’Hara, Andrew N. Pollak, Lyndsay M. O’Hara, Alexandra Herman, Christopher J. Welsh and Gerard P. Slobogean
    Citation: BMC Health Services Research 2019 19:32
  12. State policy approaches designed to provide opioid treatment options have received significant attention in addressing the opioid epidemic in the United States. In particular, expanded availability of naloxone...

    Authors: Janice Blanchard, Audrey J. Weiss, Marguerite L. Barrett, Kimberly W. McDermott and Kevin C. Heslin
    Citation: BMC Health Services Research 2018 18:971
  13. The ‘perfect’ journey through an Irish Methadone Maintenance Treatment Programme (MMTP) would have a client engage appropriately with all relevant services available to them, inclusive of psychiatry, counselli...

    Authors: Lisa Moran, Eamon Keenan and Khalifa Elmusharaf
    Citation: BMC Health Services Research 2018 18:911
  14. Access to integrated services for individuals with co-occurring substance use and mental health disorders is a long-standing public health issue. Receiving integrated treatment services are both more effective...

    Authors: James H. Ford II, Eric L Osborne, Mehret T. Assefa, Amy M McIlvaine, Ahney M King, Kevin Campbell and Mark P McGovern
    Citation: BMC Health Services Research 2018 18:431
  15. Systematic implementation of guidelines for opioid therapy management in chronic non-cancer pain can reduce opioid-related harms. However, implementation of guideline-recommended practices in routine care is s...

    Authors: Aleksandra E. Zgierska, Regina M. Vidaver, Paul Smith, Mary W. Ales, Kate Nisbet, Deanne Boss, Wen-Jan Tuan and David L. Hahn
    Citation: BMC Health Services Research 2018 18:415